496 / 604
Author/year
# pts.
LNmet/
total
Primary Fract x dose
Local
control
2-‐years
Survival
2-‐years
Severe
morbidity
Chawla 2009
30
16 pall.
Mixed
(lung;
n=20)
4 x 4Gy
10 x 5Gy
55%
(1-‐year)
44%
(1-‐year)
No
Holy 2011
13 (18)
NSCLC
5 x 4-‐8Gy
77%
50% Grade 3 (n=2)
Casamassima
2012
48
Mixed
(lung;
n=24)
3 x 12Gy
90%
40%
No
Retrospec+ve cohorts
Adrenal metastases: Local control rates 55-‐90 %